Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 133-144 of 725 results.
"This meta-analysis identifies blood transfusions, congenital/CNS comorbidities, parenteral nutrition, and catheter-related practices as critical modifiable risk factors for pediatric CLABSI” Li et al (2025).
"We present the case of a 71-year-old woman with multiple comorbidities who developed a right subpectoral hematoma with active arterial bleeding following PICC line insertion” Zoghoul et al (2025).
"Almost 1 in 3 patients leaving on OPAT experienced an adverse event. A 6 Sigma analysis identified heterogeneity in our process and incorrect assumptions among stakeholders. Next steps should focus on improving ID documentation and ensuring all patients leaving on OPAT have an ID clinic visit scheduled within 14 days after discharge” Keri et al (2025).
"A prioritization study with infection preventionists using the SHEA CLABSI prevention framework identified priorities for IVCare intervention testing as: vascular access teams, education/competency for CVAD insertion/post-insertion care, sutureless securement, connector type and decontamination method” Rickard et al (2025).
"This editorial examines the current landscape of PICC utilization in cancer care, highlighting the critical intersection between evidence-based practice and patient-centered outcomes” Mussa and Defrancisco (2025).
"Contrast-enhanced computed tomography demonstrated the absence of the left brachiocephalic vein, with the left internal jugular vein joining the left subclavian vein and descending directly to the heart, confirming persistent left superior vena cava (PLSVC)”
"In conclusion, our results support flush and discard ahead of haemostatic assay blood sampling in newly inserted catheters. Furthermore, the results enhance the understanding of central venous catheter-related thrombosis formation” Naddi et al (2025).
"Hurricane Helene's disruption of Baxter's North Carolina manufacturing facility in September 2024 created significant supply disruptions and an urgent need to reduce intravenous fluid (IVF) usage across our 12 acute care hospital health system” Nahass et al (2025).
"Two months of rivaroxaban prophylaxis effectively and safely reduce CRT incidence in breast cancer patients with PICC” Sang et al (2025).
"IJVT presents with distinct biomarker profiles when associated with CVADs, characterized by lower systemic fibrinolysis and heightened inflammation. Recognition of these differences may refine diagnostic thresholds and guide prophylactic strategies. Larger prospective studies are warranted” Boccatonda et al (2025).
"This case demonstrates the azygos vein as a viable alternative for haemodialysis access in SVC stenosis” Pushevski et al (2025).
"Chemo-port insertion is performed by a radiologist or surgeon in an interventional radiology (IR) suite or an operating room (OR). The complication rate is approximately 3%-4%. However, there is still a lack of data for comparison when it is performed in different conditions such as IR suite and OR” Park et al (2025).
